The Phosphorylation State of GluR1 Subunits Determines the Susceptibility of AMPA Receptors to Calpain Cleavage
Overview
Authors
Affiliations
The alpha-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor (AMPAR) is an ionotropic glutamate receptor that governs most of excitatory synaptic transmission in neurons. In vitro biochemical assay has shown that calpain, a Ca2+-activated protease, can cleave AMPAR GluR1 subunits. Our physiological study found that calpain, which was activated by prolonged stimulation of the N-methyl-D-aspartate receptor (100 microM, 10 min), caused a substantial suppression of AMPAR currents in cortical neurons. Since the phosphorylation sites of GluR1 by several protein kinases are located in close proximity to the calpain cleavage sites, we investigated the effect of phosphorylation on the susceptibility of GluR1 to calpain cleavage. Interestingly, we found that the calpain regulation of AMPAR currents was diminished by inhibition of Ca2+/calmodulin-dependent protein kinase II (CaMKII) but was augmented by inhibition of protein phosphatase 1/2A (PP1/2A). In agreement with this, in vitro assay showed that the calpain-induced proteolytic cleavage of GluR1 C-terminal fusion protein was strongly potentiated by adding the purified active CaMKII, and GluR1 phosphorylated at Ser831 by CaMKII is much more sensitive to calpain cleavage. Taken together, our data suggest that calpain activation suppresses AMPA receptor currents via proteolytic cleavage of GluR1 subunits, and the susceptibility of AMPARs to calpain cleavage is determined by the phosphorylation state of GluR1 subunits, which is mediated by CaMKII-PP1/2A activity.
Shah F, Li T, Al Kury L, Zeb A, Khatoon S, Liu G Front Neurol. 2019; 10:1178.
PMID: 31798514 PMC: 6868119. DOI: 10.3389/fneur.2019.01178.
Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways.
Shah F, Liu G, Al Kury L, Zeb A, Abbas M, Li T Front Pharmacol. 2019; 10:297.
PMID: 31024297 PMC: 6461025. DOI: 10.3389/fphar.2019.00297.
Wang J, Wang Y, Xu F, Zhao J, Zhou S, Yu Y Acta Pharmacol Sin. 2016; 37(3):303-11.
PMID: 26725511 PMC: 4775841. DOI: 10.1038/aps.2015.112.
Dore K, Labrecque S, Tardif C, De Koninck P PLoS One. 2014; 9(11):e112170.
PMID: 25393018 PMC: 4230936. DOI: 10.1371/journal.pone.0112170.
Russo I, Bonini D, La Via L, Barlati S, Barbon A Neuromolecular Med. 2013; 15(2):324-38.
PMID: 23494293 DOI: 10.1007/s12017-013-8221-6.